Expression of the proto-oncogene Ret, a component of the GDNF receptor complex, persists in human substantia nigra neurons in Parkinson's disease

Brain Research

Volumn 792, Issue 2, 1998, Pages 207-217

  Walker, Douglas G ^a   Beach, Thomas G ^a   Xu, Ren ^b   Lile, Jack ^b   Beck, Klaus D ^b   McGeer, Edith G ^a   L McGeer, Patrick ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b AMGEN INC   (United States)

Author keywords

Dopaminergic; Growth factor; Immunocytochemistry; Parkinson's disease; Substantia nigra; Tyrosine kinase

Indexed keywords

ONCOPROTEIN; PROTEIN TYROSINE KINASE;

ADULT; AGED; AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREACTIVITY; MACROPHAGE ACTIVATION; MALE; MONKEY; PARKINSON DISEASE; PRIORITY JOURNAL; PROTO ONCOGENE; RECEPTOR BINDING; SUBSTANTIA NIGRA; SURVIVAL RATE;

ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CELL LINE; DOPAMINE; DROSOPHILA PROTEINS; FEMALE; GENE EXPRESSION; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MONOCYTES; NEURONS; PARKINSON DISEASE; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR PROTEIN-TYROSINE KINASES; RNA, MESSENGER; SUBSTANTIA NIGRA;

EID: 0032507692     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(98)00131-0     Document Type: Article

References (51)

1. Akiyama H., McGeer P.L. Brain microglia constitutively express beta-2 integrins. J. Neuroimmunol. 30:1990;81-93.
2. Baloh R.H., Tansey M.G., Golden J.P., Creedon D.J., Heuckeroth R.O., Keck C.L., Zimonjic D.B., Popescu N.C., Johnson E.M., Milbrandt J. TrnR2, a novel receptor that mediates Neurturin and GDNF signaling through Ret. Neuron. 18:1997;793-802.
3. Biedler J.L., Roffler-Tarlov S., Schachner M., Freedman L.S. Multiple neurotransmitter synthesis by human neuroblastoma cell lines and clones. Cancer Res. 38:1978;3751-3757.
4. Bilang-Bleuel A., Revah F., Colin P., Locquet I., Robert J.-J., Mallet J., Horellou P. Intrastriatal injection of an adenoviral vector expressing glial-cell-line-derived neurotrophic factor prevents dopaminergic neuron degeneration and behavioral impairment in a rat model of Parkinson disease. Proc. Natl. Acad. Sci. USA. 94:1997;8818-8823.
5. Bowenkamp K.E., Hoffman A.F., Gerhardt G.A., Henry M.A., Biddle P.T., Hoffer B.J., Granholm A.C. Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons. J. Comp. Neurol. 355:1995;479-489.
6. Bowenkamp K.E., Lapchak P.A., Hoffer B.J., Bickford P.C. Glial cell line-derived neurotrophic factor reverses motor impairment in 16-17 month old rats. Neurosci. Lett. 211:1996;81-84.
7. Bunone B., Borrello M.G., Picetti R., Bongarzone I., Peverali F.A., DeFranciscis V., Della Valle G., Pierotti M.A. Induction of RET proto-oncogene expression in neuroblastoma cells precedes neuronal differentiation and is not mediated by protein synthesis. Exp. Cell Res. 217:1995;92-99.
8. Choi-Lundberg D.L., Lin Q., Chang Y.N., Chiang Y.L., Hay C.M., Mohajeri H., Davidson B.L., Bohn M.C. Dopaminergic neurons protected from degeneration by GDNF gene therapy. Science. 275:1997;838-841.
9. Clarkson E.D., Zawada W.M., Freed C.R. GDNF reduces apoptosis in dopaminergic neurons in vitro. Neuroreport. 7:1995;145-149.
10. Creedon D.J., Tansey M.G., Baloh R.H., Osborne P.A., Lampe P.A., Fahrner T.J., Heuckeroth R.O., Milbrandt J., Johnson E.M. Neurturin shares receptors and signal transduction pathways with glial cell line-derived neurotrophic factor in sympathetic neurons. Proc. Natl. Acad. Sci. U.S.A. 94:1997;7018-7023.
11. Durbec P., Marcos-Gutierrez C.V., Kilkenny C., Grigoriou M., Wartiowaara K., Suvanto P., Smith D., Ponder B., Costantini F., Saarma M., Sariola H., Pachnis V. GDNF signalling through the Ret receptor tyrosine kinase. Nature. 381:1996;789-793.
12. J. Fearnley, A. Lees, Pathology of Parkinson's disease, in: D.B. Calne (Ed.), Neurodegenerative Diseases, W.B. Saunders, Philadelphia, 1994, pp. 545-554.
13. Gash D.M., Zhang Z., Cass W.A., Ovadia A., Simmerman L., Martin D., Russell D., Collins F., Hoffer B.J., Gerhardt G.A. Morphological and functional effects of intranigrally administered GDNF in normal rhesus monkeys. J. Comp. Neurol. 363:1995;345-358.
14. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman L., Russell D., Martin D., Lapchak P.A., Collins F., Hoffer B.J., Gerhardt G.A. Functional recovery in parkinsonian monkeys treated with GDNF. Nature. 380:1996;252-255.
15. Gattei V., Celetti A., Cerrato A., Degan M., De Luliis A., Rossi F.M., Chiappetta G., Consales C., Improta S., Zagonei V., Aldinucci D., Agosti V., Santoro M., Vecchio G., Pinto A., Grieco M. Expression of the RET receptor tyrosine kinase and GDNFR-α in normal and leukemic human hematopoietic cells and stromal cells of the bone marrow microenvironment. Blood. 89:1997;2925-2937.
16. Hoffer B.J., Hoffman A., Bowenkamp K.E., Huettl P., Hudson J., Martin D., Lin L.F., Gerhardt G.A. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182:1994;107-111.
17. Hofstra R.M.W., Landsvater R.M., Ceccherini I., Stulp R.P., Stelwagen T., Luo Y., Pasini B., Hoppener J.M.W., Ploos van Amstel H.K., Romeo G., Lips C.J.M., Buys C.H.M. A mutation in the RET proto-oncogene associated with multiple endocrine neoplasia type 2B and sporadic medullary thyroid carcinoma. Nature. 367:1994;375-376.
18. Hou J.G., Lin L.F., Mytilineou C. Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and regrowth after damage by 1-methyl-4-phenylpyridinium. J. Neurochem. 66:1996;74-82.
19. Jing S., Wen D., Yu Y., Holst P.L., Luo Y., Fang M., Tamir R., Antonio L., Hu Z., Cupples R., Louis J.C., Hu S., Altrock B.W., Fox G.M. GDNF-induced activation of the ret protein tyrosine kinase is mediated by GDNFR-alpha, a novel receptor for GDNF. Cell. 85:1996;1113-1124.
20. Kearns C.M., Gash D.M. GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 672:1995;104-111.
21. Lapchak P.A., Jiao S., Miller P.J., Williams L.R., Cummins V., Inouye G., Matheson C.R., Yan Q. Pharmacological characterization of glial cell line-derived neurotrophic factor (GDNF): implications for GDNF as a therapeutic molecule for treating neurodegenerative diseases. Cell Tissue Res. 286:1996;179-189.
22. Lehto T., Honkanen E., Teppo A.M., Meri S. Urinary excretion of protectin (CD59), complement SC5b-9 and cytokines in membranous glomerulonephritis. Kidney Int. 47:1995;1403-1411.
23. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
24. Lin L.F., Zhang T.J., Collins F., Armes L.G. Purification and initial characterization of rat B49 glial cell line-derived neurotrophic factor. J. Neurochem. 63:1994;758-768.
25. Lindsay R.M., Yancopoulos G.D. GDNF in a bind with known orphan: accessory implicated in new twist. Neuron. 17:1996;571-574.
26. McGeer P.L., Itagaki S., Boyes B.E., McGeer E.G. Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains. Neurology. 38:1988;1285-1291.
27. McGeer P.L., McGeer E.G., Suzuki J.S. Aging and extrapyramidal function. Arch. Neurol. 34:1977;33-35.
28. Moore M.W., Klein R.D., Farinas I., Sauer H., Armanini M., Phillips H., Reichardt L.F., Ryan A.M., K Carver-Moore A. Rosenthal, Renal and neuronal abnormalities in mice lacking GDNF. Nature. 382:1996;76-79.
29. Nakamura T., Ishizaka Y., Nagao M., Hara M., Ishikawa T. Expression of the ret proto-oncogene product in human normal and neoplastic tissues of neural crest origin. J. Pathol. 172:1994;255-260.
30. Opackajuffry J., Ashworth S., Hume S.P., Martin D., Brooks D.J., Blunt S.B. GDNF protects against 6-OHDA nigrostriatal Lesion - In vivo study with microdialysis and PET. Neuroreport. 7:1995;348-352.
31. Pichel J.G., Shen L., Sheng H.Z., Granholm A.C., Drago J., Grinberg A., Lee E.J., Huang S.P., Saarma M., Hoffer B.J., Sariola H., Westphal H. Defects in enteric innervation and kidney development in mice lacking GDNF. Nature. 382:1996;73-76.
32. Romeo G., Ronchetto P., Luo Y., Barone V., Seri M., Ceccherini I., Pasini B., Bocciardi R., Lerone M., Kaariainen H. Point mutations affecting the tyrosine kinase domain of the RET proto-oncogene in Hirschsprung's disease. Nature. 367:1994;377-378.
33. Sanchez M.P., Silos-Santiago I., Frisen J., He B., Lira S.A., Barbacid M. Renal agenesis and the absence of enteric neurons in mice lacking GDNF. Nature. 382:1996;70-73.
34. Sanicola M., Hession C., Worley D., Carmillo P., Ehrenfels C., Walus L., Robinson S., Jaworski G., Wei H., Tizard R., Whitty A., Pepinsky R.B., Cate R.L. Glial cell line-derived neurotrophic factor-dependent RET activation can be mediated by two different cell-surface accessory proteins. Proc. Natl. Acad. Sci. U.S.A. 94:1997;6238-6243.
35. Schuchardt A., Agati V., Larsson-Blomberg L., Costantini F., Pachnis V. Defects in the kidney and enteric nervous system of mice lacking the tyrosine kinase receptor Ret. Nature. 367:1994;380-383.
36. Shults C.W., Kimber T., Martin D. Intrastriatal injection of GDNF attenuates the effects of 6-hydroxydopamine. Neuroreport. 7:1996;627-631.
37. Singh I.N., Sorrentino G., McCartney D.G., Massarelli R., Kanfer J.N. Enzymatic activities during differentiation of the human neuroblastoma cells, LA-N-1 and LA-N-2. J. Neurosci. Res. 25:1990;448-476.
38. Smith D.P., Eng C., Ponder B.A. Mutations of the RET proto-oncogene in the multiple endocrine neoplasia type 2 syndromes and Hirschsprung disease. J. Cell Sci. S18:1994;43-49.
39. 18F] fluorodopa studies correlate with dopamine cell counts and levels. Ann. Neurol. 34:1993;324-330.
40. Tahira T., Ishizaka Y., Itoh F., Sugimura T., Nagao M. Characterization of ret proto-oncogene mRNAs encoding two isoforms of the protein product in a human neuroblastoma cell line. Oncogene. 5:1990;97-102.
41. Takahashi M., Buma Y., Iwamoto T., Inaguma Y., Ikeda H., Hiai H. Cloning and expression of the ret proto-oncogene encoding a tyrosine kinase with two potential transmembrane domains. Oncogene. 3:1988;571-578.
42. Takahashi M., Buma Y., Taniguchi M. Identification of the ret proto-oncogene products in neuroblastoma and leukemia cells. Oncogene. 6:1991;297-301.
43. Takahashi M., Cooper G.M. ret transforming gene encodes a fusion protein homologous to tyrosine kinases. Mol. Cell. Biol. 7:1987;1378-1385.
44. Treanor J.J., Goodman L., de Sauvage F., Stone D.M., Poulsen K.T., Beck C.D., Gy C., Armanini M.P., Pollock R.A., Hefti F., Phillips H.S., Goddard A., Moore M.W., Buj-Bello A., Davies A.M., Asai N., Takahashi M., Vandlen R., Henderson C.E., Rosenthal A. Characterization of a multicomponent receptor for GDNF. Nature. 382:1996;80-83.
45. Trupp M., Arenas E., Fainzilber M., Nilsson A.S., Sieber B.A., Grigoriou M., Kilkenny C., Salazar-Grueso E., Pachnis V., Arumae U., Sariola H., Saarma M., Ibanez C.F. Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature. 381:1996;785-788.
46. Tsuchiya S., Kobayashi Y., Goto Y., Okumura H., Nakae S., Konno T., Tada K. Induction of maturation in cultured human monocytic leukemia cells by a phorbol diester. Cancer Res. 42:1982;1530-1536.
47. van Weering D.H.J., Bos J.L. Glial cell line-derived neurotrophic factor induces Ret-mediated lamellipodia formation. J. Biol. Chem. 272:1997;249-254.
48. Walker D.G., Kim S.U., McGeer P.L. Complement and cytokine gene expression in cultured microglia derived from postmortem human brains. J. Neurosci. Res. 40:1995;478-493.
49. Walker D.G., Yasuhara O., Patston P.A., McGeer E.G., McGeer P.L. Complement C1 inhibitor is produced by brain tissue and is cleaved in Alzheimer disease. Brain Res. 675:1995;75-82.
50. Wijker M., Wszolek Z.K., Wolters E.C., Rooimans M.A., Pals G., Pfeiffer R.F., Lynch T., Rodnitzky R.L., Wilhelmsen K.C., Arwert F. Localization of the gene for rapidly progressive autosomal dominant parkinsonism and dementia with pallido-ponto-nigral degeneration to chromosome 17q21. Hum. Mol. Genet. 5:1996;151-154.
51. Worby C.A., Vega Q.C., Zhao Y., Chao H.H.J., Seasholtz A.F., Dixon J.E. Glial cell line-derived neurotrophic factor signals through the RET receptor and activates mitogen-activated protein kinase. J. Biol. Chem. 271:1996;23619-23622.